首页> 美国卫生研究院文献>Infection and Immunity >Uridinediphosphogalactose-4-Epimerase Deficiency in Salmonella typhimurium and Its Correction by Plasmid-Borne Galactose Genes of Escherichia coli K-12: Effects on Mouse Virulence Phagocytosis and Serum Sensitivity
【2h】

Uridinediphosphogalactose-4-Epimerase Deficiency in Salmonella typhimurium and Its Correction by Plasmid-Borne Galactose Genes of Escherichia coli K-12: Effects on Mouse Virulence Phagocytosis and Serum Sensitivity

机译:鼠伤寒沙门氏菌中尿苷二磷酸半乳糖-4-表异构酶缺乏症及其大肠杆菌K-12质粒-半乳糖基因的校正:对小鼠毒力吞噬作用和血清敏感性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synthesis of smooth lipopolysaccharide (LPS) in relation to mouse virulence and resistance to serum bactericidal activity in vitro and to rapid intravenous clearance in vivo was studied in Salmonella typhimurium by using a virulent [median lethal dose (LD50) = 102], smooth, and genetically marked strain, a uridinediphosphogalactose epimerase-deficient mutant of it which was, therefore, rough, and a derivative of the mutant made smooth again by acquisition of the galactose-positive genes of Escherichia coli. The mutant was of reduced virulence (LD50 = 106) but the smooth derivative regained the virulence character typical of the parent. The non-smooth phenotype also made the mutant, but not the smooth relatives (parent and derivative), susceptible to serum bactericidal activity and also to rapid intravenous clearance by phagocytosis by the liver. The mutant was similarly treated by germ-free mice (expected to be relatively free of opsonizing antibodies). The clearance of the mutant could be impaired by prior intravenous inoculation of homologous bacteria or their LPS but was reversible by preopsonization of the second inoculum with nonimmune mouse serum, suggesting that the initial inoculum preempted the opsonizing antibodies. Independent evidence of clearance specificity was also provided in mixed inoculum experiments on impaired mice by the rapid clearance of an antigenically unrelated heptose-deficient mutant while maintaining the decelerated clearance of the epimerase mutant. The latter, however, was converted to accelerated clearance by the intravenous inoculation during the impaired state of anti-epimerase mutant immune mouse serum.
机译:在鼠伤寒沙门氏菌中,通过使用有毒的[中毒致死剂量(LD50)= 10 2”,研究了与小鼠毒性和体外对血清杀菌活性的抵抗以及体内对静脉内快速清除有关的平滑脂多糖(LPS)的合成。 ],光滑且具有遗传标记的菌株,该菌株缺乏尿苷二磷酸半乳糖差向异构酶,因此是粗糙的,并且该突变体的衍生物通过收购大肠杆菌的半乳糖阳性基因而再次变得光滑。该突变体的毒力降低(LD50 = 10 6 ),但平滑衍生物恢复了典型的母体毒力特征。非光滑的表型也使突变体,而不是平滑的近亲(亲本和衍生物),容易受到血清杀菌活性的影响,并且也容易被肝脏吞噬作用而迅速清除静脉。该突变体也用无菌小鼠进行了治疗(预计相对不含调理抗体)。突变体的清除可能会因事先静脉接种同源细菌或其LPS而受损,但可通过用非免疫小鼠血清对第二个接种物进行预调理来逆转,这表明最初的接种物会取代调理抗体。通过快速清除抗原无关的庚糖缺陷型突变体,同时保持差向异构酶突变体的清除率降低,在受损小鼠的混合接种实验中也提供了清除特异性的独立证据。但是,在抗表皮酶突变体免疫小鼠血清受损的状态下,通过静脉接种将后者转化为加速清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号